Designing Drug Delivery Vehicles based on N-(2-Hydroxypropyl) Methacrylamide
Ramakrishna Prasad Are1, Anju R Babu1
1Department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela, Odisha, India.
Current Computer-Aided Drug Design
|January 29, 2024
Summary
Computational methods were used to design novel copolymers for drug delivery, optimizing properties like water solubility and absorption. This research aids in developing safer, more effective drug carriers for clinical studies.
Area of Science:
- Polymer chemistry
- Computational drug design
- Pharmacokinetics
Background:
- Polymeric drug delivery systems have advanced significantly in recent years.
- Copolymers are increasingly used as drug carriers to mitigate side effects and toxicity.
Purpose of the Study:
- To computationally design novel copolymers using N-(2-Hydroxypropyl) methacrylamide, polyethylene glycol, and lauryl methacrylate.
- To perform in silico physicochemical and pharmacokinetic property analysis of designed copolymer drug carriers.
Main Methods:
- Random functional group selection for copolymer side chains.
- Utilized Swiss ADME and pkCSM servers for pharmacokinetic predictions (ADMET).
- Employed AutoDock Vina and PatchDock for molecular interactions with human serum albumin.
Main Results:
- Designed copolymers exhibit water solubility and high gastrointestinal absorption.
- One molecule showed potential for blood-brain barrier penetration; two indicated carcinogenic properties.
- Analyzed toxicity and metabolism via LD50, cytochrome P450, and P-glycoprotein interactions.
Conclusions:
- Provides insights for designing new drug compounds and carriers.
- Facilitates physicochemical property analysis for optimizing drug candidates.
- Supports the advancement of compounds for future clinical trials.
Related Concept Videos
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...